209 related articles for article (PubMed ID: 33151566)
1. Histopathologic grading and its relationship with outcome in oral tongue squamous cell carcinoma.
Silva LABD; Lopes MLDS; Sá MC; de Almeida Freitas R; Coletta RD; da Silveira EJD; da Costa Miguel MC
J Oral Pathol Med; 2021 Feb; 50(2):183-190. PubMed ID: 33151566
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of tumor budding thresholds in oral tongue squamous cell carcinoma.
Mascitti M; Togni L; Caponio VCA; Zhurakivska K; Lo Muzio L; Rubini C; Santarelli A; Troiano G
Oral Dis; 2023 Jul; 29(5):1947-1958. PubMed ID: 35316866
[TBL] [Abstract][Full Text] [Related]
3. Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer.
Almangush A; Bello IO; Keski-Säntti H; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Tommola S; Nieminen O; Soini Y; Kosma VM; Koivunen P; Grénman R; Leivo I; Salo T
Head Neck; 2014 Jun; 36(6):811-8. PubMed ID: 23696499
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the budding and depth of invasion (BD) model in oral tongue cancer biopsies.
Almangush A; Leivo I; Siponen M; Sundquist E; Mroueh R; Mäkitie AA; Soini Y; Haglund C; Nieminen P; Salo T
Virchows Arch; 2018 Feb; 472(2):231-236. PubMed ID: 28766010
[TBL] [Abstract][Full Text] [Related]
5. A Proposal to Revise the Histopathologic Grading System of Early Oral Tongue Cancer Incorporating Tumor Budding.
Elseragy A; Salo T; Coletta RD; Kowalski LP; Haglund C; Nieminen P; Mäkitie AA; Leivo I; Almangush A
Am J Surg Pathol; 2019 May; 43(5):703-709. PubMed ID: 30829728
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of TFIIH and XPF in oral tongue squamous cell carcinoma.
Sá MC; Conceição TS; de Moura Santos E; de Morais EF; Galvão HC; de Almeida Freitas R
Eur Arch Otorhinolaryngol; 2020 Mar; 277(3):893-902. PubMed ID: 31828418
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of histologic grade, worst pattern of invasion, and tumor budding in early oral tongue squamous cell carcinoma: a comparative study.
Xu B; Salama AM; Valero C; Yuan A; Khimraj A; Saliba M; Zanoni DK; Ganly I; Patel SG; Katabi N; Ghossein R
Virchows Arch; 2021 Sep; 479(3):597-606. PubMed ID: 33661329
[TBL] [Abstract][Full Text] [Related]
8. Exploring the combination of tumor-stroma ratio, tumor-infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early-stage oral squamous cell carcinoma prognosis.
Silva GVD; da Silva Dolens E; Paranaíba LMR; Ayroza ALC; Gurgel Rocha CA; Almangush A; Salo T; Brennan PA; Coletta RD
J Oral Pathol Med; 2023 May; 52(5):402-409. PubMed ID: 36149755
[TBL] [Abstract][Full Text] [Related]
9. Pattern and localization of perineural invasion predict poor survival in oral tongue carcinoma.
Caponio VCA; Troiano G; Togni L; Zhurakivska K; Santarelli A; Laino L; Rubini C; Lo Muzio L; Mascitti M
Oral Dis; 2023 Mar; 29(2):411-422. PubMed ID: 33964054
[TBL] [Abstract][Full Text] [Related]
10. For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality.
Almangush A; Bello IO; Coletta RD; Mäkitie AA; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kosma VM; Koivunen P; Kelner N; Kowalski LP; Grénman R; Leivo I; Läärä E; Salo T
Virchows Arch; 2015 Jul; 467(1):39-46. PubMed ID: 25838076
[TBL] [Abstract][Full Text] [Related]
11. Addition of the tumour-stroma ratio to the 8th edition American Joint Committee on Cancer staging system improves survival prediction for patients with oral tongue squamous cell carcinoma.
Mascitti M; Zhurakivska K; Togni L; Caponio VCA; Almangush A; Balercia P; Balercia A; Rubini C; Lo Muzio L; Santarelli A; Troiano G
Histopathology; 2020 Nov; 77(5):810-822. PubMed ID: 32633006
[TBL] [Abstract][Full Text] [Related]
12. Cortactin expression in a Norwegian cohort of human papilloma virus negative oral squamous cell carcinomas of the mobile tongue.
Sengüven Toközlü B; Sapkota D; Vallenari EM; Schreurs O; Søland TM
Eur J Oral Sci; 2023 Apr; 131(2):e12925. PubMed ID: 36790139
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.
Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T
Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291
[TBL] [Abstract][Full Text] [Related]
14. Tumor-stroma ratio can predict lymph-node metastasis in cT1/2N0 oral tongue squamous cell carcinoma independent of tumor budding grade.
Sakai T; Saito Y; Tateishi Y; Yamazawa S; Fukuoka O; Kobayashi K; Omura G; Akashi K; Yoshida M; Ando M; Ebihara Y; Yamasoba T
Int J Clin Oncol; 2022 Dec; 27(12):1818-1827. PubMed ID: 36197545
[TBL] [Abstract][Full Text] [Related]
15. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
[TBL] [Abstract][Full Text] [Related]
16. The prognostic role of single cell invasion and nuclear diameter in early oral tongue squamous cell carcinoma.
Almangush A; Hagström J; Haglund C; Kowalski LP; Coletta RD; Mäkitie AA; Salo T; Leivo I
BMC Cancer; 2024 Feb; 24(1):213. PubMed ID: 38360653
[TBL] [Abstract][Full Text] [Related]
17. A simple novel prognostic model for early stage oral tongue cancer.
Almangush A; Coletta RD; Bello IO; Bitu C; Keski-Säntti H; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Tommola S; Soini Y; Kosma VM; Koivunen P; Kowalski LP; Nieminen P; Grénman R; Leivo I; Salo T
Int J Oral Maxillofac Surg; 2015 Feb; 44(2):143-50. PubMed ID: 25457829
[TBL] [Abstract][Full Text] [Related]
18. EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma.
Liu L; Wang X; Ge W
Med Sci Monit; 2018 Oct; 24():7213-7222. PubMed ID: 30300334
[TBL] [Abstract][Full Text] [Related]
19. Tertiary lymphoid structures associate with improved survival in early oral tongue cancer.
Almangush A; Bello IO; Elseragy A; Hagström J; Haglund C; Kowalski LP; Nieminen P; Coletta RD; Mäkitie AA; Salo T; Leivo I
BMC Cancer; 2022 Oct; 22(1):1108. PubMed ID: 36309667
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T
J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
